Schedule 13G ownership disclosure

Apogee Therapeutics Inc

Common Stock · CUSIP: 03770N101

Event date: 2025-09-30

Filing-level shares
2,158,502
Percent of class
4.68%
  • DRIEHAUS CAPITAL MANAGEMENT LLC

    Shares: 2,158,502 · Class: 4.68%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000938206-25-000048
Form type
SCHEDULE 13G/A
Filer
Apogee Therapeutics, Inc.
CIK
CIK 1974640
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub